Elsevier

Ophthalmology

Volume 124, Issue 1, January 2017, Pages 139-141
Ophthalmology

Report
Special Report: American Academy of Ophthalmology Task Force Consensus Statement for Extended Depth of Focus Intraocular Lenses

https://doi.org/10.1016/j.ophtha.2016.09.039Get rights and content

Section snippets

Consensus Statement

The criteria for EDF IOLs are as follows:

The EDF IOL group should consist of a minimum of 100 patients. The control group cohort should be similar for comparisons. The EDF IOLs need to demonstrate comparable monocular mean best-corrected distance visual acuity (BCDVA).

The monocular depth of focus for the EDF-implanted eyes needs to be at least 0.5 diopters (D) greater than the depth of focus for the monofocal IOL controls at logMAR 0.2 (20/32) (see Defocus Curve Testing Methodology, below).

The

First page preview

First page preview
Click to open first page preview

References (0)

Cited by (0)

Financial Disclosure(s): The author(s) have made the following disclosure(s): J.T.H.: Consultant –Abbott Medical Optics (Milpitas, CA); Alcon Laboratories, Inc. (Fort Worth, TX); Carl Zeiss, Inc. (Oberkochen, Germany); Oculus, Inc. (Wetzlar, Germany); Consultant and Equity Owner – AcuFocus, Inc. (Irvine, CA); ArcScan (Morrison, CO); Elenza (Roanoke, VA); Visiometrics (Barcelona, Spain).

A.G.: Consultant – Abbott Medical Optics, LensAR (Orlando, FL); Medicem (Cheshire, UK); Refocus Group (Dallas, TX); Tracey Technologies (Houston, TX); Vista Ocular (North Canton, OH); Consultant and Equity Owner – Encore Vision (Fort Worth, TX); LensGen (Irvine, CA); PowerVision (Belmont, CA).

The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the Department of Health and Human Services (DHHS). The following authors: M.E.T., G.H., T.N., E.R., D.C., and M.E. are employees of the U.S. Government and prepared this work as part of their official duties. Title 17, USC, § 105 provides that copyright protection under this title is not available for any work of the United States Government. Title 17, USC, § 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties.

The American Academy of Ophthalmology Task Force for Developing Novel End Points for Premium Intraocular Lenses members include: Jack T. Holladay, MD, MSEE, Chair; Adrian Glasser, PhD, Co-Chair; Scott MacRae, MD, Co-Chair; Samuel Masket, MD; Walter Stark, MD; and the following U.S. Food and Drug Administration staff members: Malvina Eydelman, MD; Don Calogero, MS; Gene Hilmantel, OD; Eva Rorer, MD; Tieuvi Nguyen, PhD; and Michelle E. Tarver, MD, PhD.

Correspondence: Flora Lum, MD, American Academy of Ophthalmology, Division of Quality and Data Science, 655 Beach Street, San Francisco, CA 94109-1336. E-mail: [email protected].

View full text